SAN DIEGO – All multiple sclerosis patients taking natalizumab (Tysabri) who were diagnosed with progressive multifocal leukoencephalopathy (PML) before symptoms appeared were still alive a year later ...

BARCELONA, Spain — A quantitative test for antibodies to the JC virus (JCV) stratifies antibody-positive patients with multiple sclerosis (MS) for their risk of contracting progressive multifocal ...

The promyelocytic leukaemia (PML) gene is translocated in most acute promyelocytic leukaemias and encodes a tumour suppressor protein. PML is involved in multiple apoptotic pathways and is thought to ...

May 31, 2011 — The prognosis of natalizumab (Tysabri; Biogen Idec)–associated progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis (MS) appears to be better than for ...

The control of cell fate in neural progenitor cells is critical for nervous system development. Nevertheless, the processes involved are only partially known. We found that the expression of the tumor ...